Maram Attiq

Maram Attiq practices at Corewell Health Dearborn Hospital in Dearborn, Michigan, part of Corewell Health.

Maram Attiq's NPI, 1790104792, was assigned on April 8, 2014. Maram Attiq holds Michigan license 4301105714.

Maram Attiq's primary practice is Corewell Health Dearborn Hospital, at 18101 Oakwood Blvd, Dearborn, MI 48124 in Wayne County. The practice phone is (313) 593-7125.

Maram Attiq's primary practice is Corewell Health Dearborn Hospital in Dearborn, Michigan, part of Corewell Health. Maram Attiq is also affiliated with DMC Harper University Hospital. The medical group on file is Medical Education Associates. Dmand AI also links Maram Attiq to 1 more hospital and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Maram Attiq practices, 3 sites in all. Vendor and product names are available with a free account.

Anesthesiology is Maram Attiq's primary specialty in the NPI Registry, under taxonomy code 207L00000X. Maram Attiq is licensed in Michigan.

CMS data shows 104 Medicare services from Maram Attiq across 6 procedure codes in 2024, for 212 Medicare patients. Medicare paid $7,185 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 212 Medicare patients who saw Maram Attiq in 2024. The largest group is 65 to 74, with 84 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Maram Attiq's median patient age at 65, with 51% women.

In 2017, Maram Attiq wrote 17 Medicare Part D claims. They cover 1 drug, with $1,707 in total drug cost.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 25 general payments to Maram Attiq from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 56% of the total. Edwards Lifesciences Corporation paid the most, $1,393.